JP2016521684A5 - - Google Patents

Download PDF

Info

Publication number
JP2016521684A5
JP2016521684A5 JP2016515094A JP2016515094A JP2016521684A5 JP 2016521684 A5 JP2016521684 A5 JP 2016521684A5 JP 2016515094 A JP2016515094 A JP 2016515094A JP 2016515094 A JP2016515094 A JP 2016515094A JP 2016521684 A5 JP2016521684 A5 JP 2016521684A5
Authority
JP
Japan
Prior art keywords
solution
hypochlorous acid
magnesium
amount
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016515094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016521684A (ja
JP6416227B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/039202 external-priority patent/WO2014190184A1/en
Publication of JP2016521684A publication Critical patent/JP2016521684A/ja
Publication of JP2016521684A5 publication Critical patent/JP2016521684A5/ja
Application granted granted Critical
Publication of JP6416227B2 publication Critical patent/JP6416227B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016515094A 2013-05-22 2014-05-22 安定化次亜塩素酸溶液及びその使用 Expired - Fee Related JP6416227B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361826382P 2013-05-22 2013-05-22
US61/826,382 2013-05-22
PCT/US2014/039202 WO2014190184A1 (en) 2013-05-22 2014-05-22 Stabilized hypochlorous acid solution and use thereof

Publications (3)

Publication Number Publication Date
JP2016521684A JP2016521684A (ja) 2016-07-25
JP2016521684A5 true JP2016521684A5 (OSRAM) 2017-06-29
JP6416227B2 JP6416227B2 (ja) 2018-10-31

Family

ID=51934166

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016515094A Expired - Fee Related JP6416227B2 (ja) 2013-05-22 2014-05-22 安定化次亜塩素酸溶液及びその使用

Country Status (6)

Country Link
US (2) US9918477B2 (OSRAM)
EP (1) EP2999341B1 (OSRAM)
JP (1) JP6416227B2 (OSRAM)
CA (1) CA2913137A1 (OSRAM)
MX (1) MX373524B (OSRAM)
WO (1) WO2014190184A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5723084B2 (ja) 2006-01-20 2015-05-27 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 酸化還元電位水溶液を用いた副鼻腔炎の予防または治療方法
WO2014190184A1 (en) 2013-05-22 2014-11-27 Oculus Innovative Sciences, Inc. Stabilized hypochlorous acid solution and use thereof
KR20200034722A (ko) 2017-06-28 2020-03-31 콜리디온, 인코포레이티드 세척, 소독 및/또는 살균을 위한 조성물, 방법 및 용도
WO2019140408A1 (en) 2018-01-14 2019-07-18 Collidion, Inc. Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating
CA3130277A1 (en) 2019-02-20 2020-08-27 Biiosmart Technologies Llc Hypochlorous acid intravenous solution, preparation, and method of use thereof
LU101842B1 (en) 2020-06-08 2021-12-08 Arnaud Mainnemare Pharmaceutical Composition for treating or preventing lesions and infections in a mammal
US11097945B1 (en) 2020-11-04 2021-08-24 Cougar Creek Electrolysed Water, Llc Methods and systems for production of an aqueous hypochlorous acid solution
IT202000028082A1 (it) 2020-11-23 2022-05-23 Md Italy Srl Composizione, preparazione ed impiego di una miscela a base di bromo per l’igiene perioculare, il trattamento e la prevenzione delle blefariti

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001041571A1 (en) * 1999-12-10 2001-06-14 Kao Corporation Microbicide compositions
JP3554749B2 (ja) * 2001-02-22 2004-08-18 株式会社アクシス 殺菌消毒剤
US20050196462A1 (en) 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
US20050139808A1 (en) 2003-12-30 2005-06-30 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and process for producing same
US9168318B2 (en) 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
CA2553943C (en) 2003-12-30 2014-02-11 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution, processes for producing same and methods of using the same
ES2701153T3 (es) 2005-03-23 2019-02-21 Sonoma Pharmaceuticals Inc Método para tratar úlceras de piel utilizando una solución con agua de potencial reductivo oxidativo
CN101163491B (zh) 2005-03-23 2017-04-19 奥古露丝创新科学公司 利用氧化还原电位水溶液治疗皮肤溃疡的方法
CA2606734C (en) 2005-05-02 2016-06-21 Oculus Innovative Sciences, Inc. Method of using oxidative reductive potential water solution in dental applications
JP5723084B2 (ja) 2006-01-20 2015-05-27 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 酸化還元電位水溶液を用いた副鼻腔炎の予防または治療方法
EP2136819A1 (en) 2007-03-13 2009-12-30 Oculus Innovative Sciences, Inc. Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same
US10342825B2 (en) * 2009-06-15 2019-07-09 Sonoma Pharmaceuticals, Inc. Solution containing hypochlorous acid and methods of using same
MX365380B (es) 2009-07-30 2019-05-31 Invekra S A P I De C V Formulacion de hidrogel que comprende agua con ppotencial de oxidacion-reduccion.
GB2488838A (en) 2011-03-11 2012-09-12 Biomimetics Health Ind Ltd A stable antimicrobial aqueous hypochlorous acid solution
WO2014190184A1 (en) 2013-05-22 2014-11-27 Oculus Innovative Sciences, Inc. Stabilized hypochlorous acid solution and use thereof

Similar Documents

Publication Publication Date Title
JP2016521684A5 (OSRAM)
JP2012530142A5 (OSRAM)
JP2022075813A (ja) ジクアホソル含有点眼液
JP2014515737A5 (OSRAM)
MX2020014000A (es) Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas.
MX2016006197A (es) Formulaciones de compuestos de azaindol.
RU2015126801A (ru) Фторид-стабильные цинкосодержащие композиции для ухода за полостью рта
JP2009523832A5 (OSRAM)
JP2010514799A5 (OSRAM)
RU2012155188A (ru) Композиции для ухода за полостью рта, устойчивые к микробному росту
BR112017007144A2 (pt) ácido valproico ou um sal farmaceuticamente aceitável do mesmo, composto, composição farmacêutica, e, composto ou composição para uso, uso, método ou composição.
JP2013535549A5 (OSRAM)
CN104488957A (zh) 循环水系统用高效复合杀菌剂及其制备方法
EP4631569A3 (en) Alginate film comprising a triptan
MY161032A (en) Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
NZ605860A (en) Use of vitamin c, and chromium-free vitamin k or 2-methyl-1,4-naphthalendione, and compositions thereof for treating a polycystic disease
PH12015501793B1 (en) Bicyclic compounds
MX2015016057A (es) Solucion estabilizada de acido hipocloroso y uso de la misma.
WO2013086243A3 (en) Phospholipid compositions enriched for palmitoleic, myristoleic or lauroleic acid, their preparation and their use in treating metabolic and cardiovascular disease
JP2013509378A5 (OSRAM)
CN103735570A (zh) 一种预防口腔真菌感染的口腔护理液
CN105410021A (zh) 一种无刺激日用消毒水
MX2009006673A (es) Sales farmaceuticamente aceptables de timodepresion y procedimientos para su fabricacion.
TW200745155A (en) Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid
JP2006160607A5 (OSRAM)